The beneficial effects of FGF21 on metabolic health are well recognized; thus, in the future, it is important to evaluate whether FGF21 inducible approach utilizing nutrients and/or pharmaceutical agents is beneficial for the prevention of diabetic complications and metabolic diseases in T1DM patients. This evidence concerns the gene FGF21 and type 1 diabetes mellitus.